[HTML][HTML] What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
SK Sharma, K Dheda - Indian Journal of Medical Research, 2019 - journals.lww.com
The burden of isoniazid-resistant tuberculosis (Hr-TB) and multidrug-and/or rifampicin
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
SK Sharma, K Dheda - The Indian Journal of Medical Research, 2019 - europepmc.org
The burden of isoniazid-resistant tuberculosis (Hr-TB) and multidrug-and/or rifampicin mono-
resistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
resistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
S Sharma, K Dheda - The Indian Journal of Medical Research, 2019 - search.proquest.com
According to the first National Anti-Tuberculosis Drug Resistance Survey (NDRS) in India,
resistance to any fluoroquinolone (FQ) was found in about eight per cent of Hr-TB and …
resistance to any fluoroquinolone (FQ) was found in about eight per cent of Hr-TB and …
[PDF][PDF] What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
SK Sharma, K Dheda - INDIAN JOURNAL OF MEDICAL …, 2019 - researchonline.lshtm.ac.uk
The burden of isoniazid-resistant tuberculosis (Hr-TB) and multidrug-and/or rifampicin
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
[HTML][HTML] What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
SK Sharma, K Dheda - The Indian Journal of Medical Research, 2019 - ncbi.nlm.nih.gov
The burden of isoniazid-resistant tuberculosis (Hr-TB) and multidrug-and/or rifampicin
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
[引用][C] What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
SK Sharma, K Dheda - 2019 - pesquisa.bvsalud.org
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment? |
IMSEAR loading Conteúdo principal 1 Busca 2 Rodapé 3 +A A -A Alto contraste Portal …
IMSEAR loading Conteúdo principal 1 Busca 2 Rodapé 3 +A A -A Alto contraste Portal …
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
S Sharma, K Dheda - Indian Journal of Medical Research, 2019 - go.gale.com
The burden of isoniazid-resistant tuberculosis (Hr-TB) and multidrug-and/or rifampicin mono-
resistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
resistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
SK Sharma, K Dheda - The Indian journal of medical …, 2019 - pubmed.ncbi.nlm.nih.gov
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment? What
is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment? Indian J …
is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment? Indian J …
What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
SK Sharma, K Dheda - The Indian Journal of Medical Research, 2019 - europepmc.org
The burden of isoniazid-resistant tuberculosis (Hr-TB) and multidrug-and/or rifampicin
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …
monoresistant tuberculosis (MDR/RR-TB) is increasing worldwide, and the high TB burden …